MOXIVIB CV 1.2 INJECTIONAMOXYCILLIN 1000mg. IP + CLAVULANIC ACID 200mg. IP

Moxivib CV 1.2 Injection is an antibiotic injection used for bacterial infections of the respiratory tract, skin and urinary tract. Main uses: treatment of lower respiratory tract infections caused by susceptible beta-lactamase-producing isolates of Haemophilus influenzae and Moraxella catarrhalis; treatment of acute bacterial otitis media caused by susceptible beta-lactamase-producing isolates of H. influenzae and M. catarrhalis; treatment of sinusitis caused by susceptible beta-lactamase-producing isolates of H. influenzae and M. catarrhalis; treatment of skin and skin structure infections caused by susceptible beta-lactamase-producing isolates of Staphylococcus aureus, Escherichia coli and Klebsiella species; treatment of urinary tract infections caused by susceptible beta-lactamase-producing isolates of E. coli, Klebsiella species and Enterobacter species.

Common side effects of Moxivib CV 1.2 Injection include diarrhoea or loose stools; nausea; skin rash and urticaria (hives); vomiting; vaginitis; abdominal discomfort. Get medical help at once if you notice serious and occasionally fatal hypersensitivity (anaphylactic) reactions; severe cutaneous adverse reactions (rash progressing to serious skin reactions); liver dysfunction and cholestatic jaundice.

Moxivib CV 1.2 Injection contains Amoxycillin 1000 mg + Clavulanic Acid 200 mg. Moxivib CV 1.2 Injection is given by a doctor or nurse, who decides the dose and how often it is given.

The MRP of Moxivib CV 1.2 Injection is ₹152.31 for a pack of 1. For chemists and distributors, the PTR is ₹116.05 and the PTS is ₹104.44.

Moxivib CV 1.2 Injection contains Amoxycillin 1000 mg + Clavulanic Acid 200 mg. It comes in a pack of 1.

The amoxycillin in Moxivib CV 1.2 Injection is a penicillin-type antibiotic that prevents susceptible bacteria from forming cell walls, which they need to survive. Clavulanic Acid is a beta-lactamase inhibitor. It blocks the enzyme that some bacteria produce to break down amoxycillin, so the antibiotic can keep working against those bacteria.

Must not be used in patients with a history of a serious hypersensitivity reaction (e.g. anaphylaxis or Stevens-Johnson syndrome) to amoxycillin, clavulanic acid or other beta-lactams such as penicillins and cephalosporins. Must not be used in patients with a previous history of cholestatic jaundice or liver dysfunction linked to amoxycillin and clavulanic acid. Must not be used in patients with mononucleosis, as they develop a skin rash with this medicine. Check with a doctor first in patients with liver impairment, as liver function tests should be monitored. Check with a doctor first in patients with a history of penicillin allergy or sensitivity to multiple allergens.

Moxivib CV 1.2 Injection is a brand of Vibcare Pharma, sold through its Prima division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.